Sopan Pharmaceuticals Limited

Q: How many shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE (Ownership Structure)?

A total of 1,71,60,000 (1.7 Crore) shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.

Q: What is the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL)?

As of November 06, 2026, the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL) is Rs. 608 (2, 0.33%) . Today, the stock opened at Rs. 605 , reached a high of Rs. 611 , and a low of Rs. 605 . The previous closing price was Rs. 606 , with a turnover of Rs. 7740815.7 and a trading volume of 12724 shares across 229 trades .

SOPL

Manufacturing And Processing Listed Website ↗

Rs608 +2 ▲ 0.33%

As of Fri, Nov 06 · 02:59 PM

EPS

2.23

P/E Ratio

272.65

Book Value

121.41

PBV

5.01

1Y Yield

99.93%

Face Value

100

Fundamentals as of Q4 · 082-083

Overview Price History Dividend History

Price Chart

Price Range

Today

605 611

52 Week

276.5 1,217

All Time

276.5 1,217

Today's Trading

Open: 605
High: 611
Low: 605
Prev. Close: 606
Volume: 12,724
Trades: 229
Turnover: Rs 77.41 Lakh

Ownership

Public25% · 42.90 Lakh

Promoter75% · 1.29 Cr

Listed Shares1,71,60,000

General Information

Market Cap

Rs 10.43 Arab

Float Market Cap

Rs 2.61 Arab

Paid-up Capital

Rs 1.72 Arab

120-Day Avg

747.68

180-Day Avg

747.68

All-Time High

1,217 · Jun 22, 2026

Listed On

Jun 05, 2026

Unlocking Date

Apr 30, 2029

Sector

Manufacturing And Processing

Latest Dividend

No dividend data

Latest Right Share

No right share data

About Sopan Pharmaceuticals Limited

Sopan Pharmaceuticals Limited (SOPL) is listed under "Manufacturing And Processing" sector at Nepal Stock Exchange (NEPSE) on June 05, 2026 with a market capitalization of NPR 10,43,32,80,000 (10.4 Arab) and a float market capitalization of NPR 2,60,83,20,000 (2.6 Arab). It has a total of 1,71,60,000 (1.7 Crore) listed shares, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.

By market capitalization, Sopan Pharmaceuticals Limited (SOPL) ranks #14 of 18 actively traded Manufacturing And Processing companies on NEPSE.

Frequently Asked Questions

What is the total market capitalization (Market Cap.) and valuation of Sopan Pharmaceuticals Limited (SOPL)?

Sopan Pharmaceuticals Limited (SOPL) has a total market capitalization of NPR 10,43,32,80,000 (10.4 Arab) and a float market capitalization of NPR 2,60,83,20,000 (2.6 Arab). The book value stands at 121.41, resulting in a price-to-book value (PBV) of 5.01. The face value of each share is Rs. 100.

How many shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE (Ownership Structure)?

A total of 1,71,60,000 (1.7 Crore) shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.

What is the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL)?

As of November 06, 2026, the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL) is Rs. 608 (2, 0.33%). Today, the stock opened at Rs. 605, reached a high of Rs. 611, and a low of Rs. 605. The previous closing price was Rs. 606, with a turnover of Rs. 7740815.7 and a trading volume of 12724 shares across 229 trades.

What are the historical price trends and performance of Sopan Pharmaceuticals Limited (SOPL)?

Over the past year, Sopan Pharmaceuticals Limited (SOPL) has seen a 52-week high of Rs. 1217 and a low of Rs. 276.5. The all-time high was Rs. 1217 on June 22, 2026, while the all-time low was Rs. 276.5 on June 08, 2026. The 120-day average price is Rs. 747.68, and the 180-day average is Rs. 747.68. The 1-year yield is currently 99.93%.

What are the key financial metrics and performance indicators for Sopan Pharmaceuticals Limited (SOPL)?

Sopan Pharmaceuticals Limited (SOPL) has an earnings per share (EPS) of 2.23 and a P/E ratio of 272.65. The book value per share is 121.41, and the price-to-book value (PBV) is 5.01. The stock's 1-year yield is 99.93%, and its fiscal year data is reported for 082-083, Q4. The paid-up capital is Rs. 1,71,60,00,000.

When was Sopan Pharmaceuticals Limited (SOPL) listed on NEPSE?

Sopan Pharmaceuticals Limited (SOPL) was listed on the Nepal Stock Exchange (NEPSE) on June 05, 2026 under the Manufacturing And Processing sector.

How does Sopan Pharmaceuticals Limited (SOPL) compare with other Manufacturing And Processing companies on NEPSE?

By market capitalization, Sopan Pharmaceuticals Limited (SOPL) ranks #14 of 18 actively traded Manufacturing And Processing companies listed on NEPSE. Its last traded price of Rs 608 sits at about 35% of the way between its 52-week low of Rs 276.5 and 52-week high of Rs 1217.

When is the promoter unlocking date for Sopan Pharmaceuticals Limited (SOPL)?

The promoter unlocking date for Sopan Pharmaceuticals Limited (SOPL) is on April 30, 2029. This date marks the end of the lock-in period for the company's promoter (eligible promoters, local people, employees etc.) shares, allowing promoters to trade them freely on the stock exchange.